SCHEMBL24288095

SCHEMBL24288095

COc1ccc(-c2cnc(NC3CCCC(OC)C3)nc2C)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 7/20 0.44
▸ EIF2AK2 P19525 1/20 0.39
▸ MAPK9 P45984 4/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ BCL6 P41182 1/20 0.37
▸ AXL P30530 1/20 0.37
▸ MERTK Q12866 1/20 0.37
▸ MAPK6 Q16659 3/20 0.36
▸ SYK P43405 1/20 0.36
▸ MCHR1 Q99705 1/20 0.35
▸ AMY1A P0DUB6 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30838108 0.99 MAPK8 (0.43) MAPK8EIF2AK2MAPK9ADORA2AADORA1
SCHEMBL30838069 0.82 IRAK4 (0.41) MAPK8ADORA2AADORA1MAPK6MCHR1
Hydrochloric Acid SCHEMBL30838058 0.79 CCNK (0.44) ADORA2AADORA1ALDH1A1
Hydrochloric Acid SCHEMBL30837996 0.78 NSD2 (0.44) MAPK8ADORA2AADORA1BCL6MAPT
SCHEMBL30838096 0.75 CDK2 (0.40) MAPK8MAPK9MCHR1
SCHEMBL30838060 0.72 CYP11B1 (0.41) MAPK6SYK
Hydrochloric Acid SCHEMBL30838012 0.72 CYP11B1 (0.41) MAPK6SYK
SCHEMBL30838013 0.71 IRAK4 (0.40) MAPK8ADORA2AADORA1MAPK6MCHR1
SCHEMBL24288146 0.70 HRH4 (0.42) ADORA2AADORA1AXL
SCHEMBL24288103 0.70 IRAK4 (0.39) MAPK8ADORA2AADORA1MAPK6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022053823-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR Cerevance, Inc. (US) 2022-03-17 — — WO disclosed
Send feedback